Portland, OR, United States of America

Ashlee Moses

This inventor holds 1 USPTO granted patent. Top assignee: Oregon Health & Science University. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ashlee Moses: Innovator in Viral Reactivation Research

Introduction

Ashlee Moses is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of viral research, particularly in the area of latent virus reactivation. His work is essential for advancing our understanding of viral behavior and potential treatments.

Latest Patents

Ashlee Moses holds a patent titled "Dendritic-marker expressing macrophage cultures and methods of reactivating latent virus." This invention provides methods for latent virus reactivation in monocyte-derived macrophages through allogeneic stimulation of peripheral blood mononuclear cells (PBMC). It also includes methods for culturing viruses and cultures of virally permissive monocyte-derived macrophages. This patent highlights his innovative approach to tackling complex viral challenges.

Career Highlights

Moses is affiliated with Oregon Health & Science University, where he conducts his research. His work has garnered attention for its potential applications in medical science and virology. With 1 patent to his name, he is recognized for his contributions to the scientific community.

Collaborations

Some of his notable coworkers include Cecilia E Soderberg-Naucler and Kenneth N Fish. Their collaborative efforts contribute to the advancement of research in the field.

Conclusion

Ashlee Moses is a pioneering inventor whose work in viral reactivation is paving the way for future research and potential therapies. His contributions are vital to the ongoing exploration of viral behavior and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…